Sperling RA, Rentz DM, Johnson KA, Karlawish J, Donohue M, Salmon DP, et al. The A4 Study: stopping AD before symptoms begin? Sci Transl Med. 2014;6(228):228fs13.
Article
PubMed
PubMed Central
CAS
Google Scholar
Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–62.
Article
PubMed
PubMed Central
Google Scholar
Thomas KR, Bangen KJ, Weigand AJ, Edmonds EC, Wong CG, Cooper S, et al. Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration. Neurology. 2020;94(4):e397–406.
Article
PubMed
PubMed Central
Google Scholar
Thomas KR, Edmonds EC, Eppig J, Salmon DP, Bondi MW, Initiative ADN. Using neuropsychological process scores to identify subtle cognitive decline and predict progression to mild cognitive impairment. J Alzheimers Dis. 2018;64(1):195–204.
Article
PubMed
PubMed Central
Google Scholar
Amariglio RE, Becker JA, Carmasin J, Wadsworth LP, Lorius N, Sullivan C, et al. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia. 2012;50(12):2880–6.
Article
PubMed
PubMed Central
Google Scholar
Buckley RF, Sikkes S, Villemagne VL, Mormino EC, Rabin JS, Burnham S, et al. Using subjective cognitive decline to identify high global amyloid in community-based samples: a cross-cohort study. Alzheimers Dement. 2019;11(C):670–8.
Google Scholar
Rabin LA, Smart CM, Amariglio RE. Subjective cognitive decline in preclinical Alzheimer’s disease. Annu Rev Clin Psychol. 2017;13(1):369–96.
Article
PubMed
Google Scholar
Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement. 2014;10(6):844–52.
Article
PubMed
PubMed Central
Google Scholar
Chen X, Farrell ME, Moore W, Park DC. Actual memory as a mediator of the amyloid-subjective cognitive decline relationship. Alzheimers Dement. 2019;11:151–60.
Google Scholar
Kielb S, Rogalski E, Weintraub S, Rademaker A. Objective features of subjective cognitive decline in a United States national database. Alzheimers Dement. 2017;13(12):1337–44.
Article
PubMed
PubMed Central
Google Scholar
Koppara A, Wagner M, Lange C, Ernst A, Wiese B, König HH, et al. Cognitive performance before and after the onset of subjective cognitive decline in old age. Alzheimers Dement. 2015;1(2):194–205.
Google Scholar
Bubbico G, Di Iorio A, Lauriola M, Sepede G, Salice S, Spina E, et al. Subjective cognitive decline and nighttime sleep alterations, a longitudinal analysis. Front Aging Neurosci. 2019;11:142.
Snitz BE, Wang T, Cloonan YK, Jacobsen E, Chang CCH, Hughes TF, et al. Risk of progression from subjective cognitive decline to mild cognitive impairment: the role of study setting. Alzheimers Dement. 2018;14(6):734–42.
Article
PubMed
PubMed Central
Google Scholar
Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, et al. Subjective cognitive decline and rates of incident Alzheimer’s disease and non–Alzheimer’s disease dementia. Alzheimers Dement. 2019;15(3):465–76.
Article
PubMed
Google Scholar
Morrison C, Dadar M, Shafiee N, Villeneuve S, Louis CD. Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline. NeuroImage Clin. 2022;33:102923.
Article
PubMed
Google Scholar
Zlatar ZZ, Muniz MC, Espinoza SG, Gratianne R, Gollan TH, Galasko D, et al. Subjective cognitive decline, objective cognition, and depression in older Hispanics screened for memory impairment. J Alzheimers Dis. 2018;63(3):949–56.
Article
PubMed
PubMed Central
Google Scholar
Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19(3):271–8.
Article
PubMed
PubMed Central
Google Scholar
Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9(1):119–28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jedynak BM, Lang A, Liu B, Katz E, Zhang Y, Wyman BT, et al. A computational neurodegenerative disease progression score: method and results with the Alzheimer’s disease neuroimaging initiative cohort. NeuroImage. 2012;63(3):1478–86.
Article
PubMed
Google Scholar
Thomas KR, Eppig J, Edmonds EC, Jacobs DM, Libon DJ, Au R, et al. Word-list intrusion errors predict progression to mild cognitive impairment. Neuropsychology. 2018;32(2):235–45.
Article
PubMed
PubMed Central
Google Scholar
Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. Subtle cognitive decline and biomarker staging in preclinical Alzheimer’s disease. J Alzheimers Dis. 2015;47(1):231–42.
Article
PubMed
PubMed Central
Google Scholar
Thomas KR, Bangen KJ, Weigand AJ, Edmonds EC, Sundermann E, Wong CG, et al. Type 2 diabetes interacts with Alzheimer disease risk factors to predict functional decline. Alzheimer Dis Assoc Disord. 2020;34(1):10–7.
Article
PubMed
PubMed Central
Google Scholar
Thomas KR, Osuna JR, Weigand AJ, Edmonds EC, Clark AL, Holmqvist S, et al. Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline. J Cereb Blood Flow Metab. 2021;41(5):1001–12.
Thomas KR, Bangen KJ, Edmonds EC, Weigand AJ, Walker KS, Bondi MW, et al. Objective subtle cognitive decline and plasma phosphorylated tau181: early markers of Alzheimer’s disease-related declines. Alzheimers Dement. 2021;13(1):e12238.
Google Scholar
Cui L, Zhang Z, Zac Lo CY, Guo Q. Local functional MR change pattern and its association with cognitive function in objectively-defined subtle cognitive decline. Front Aging Neurosci. 2021;13:684918.
Aschenbrenner AJ, Gordon BA, Benzinger TLS, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. 2018;91(9):e859–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bucci M, Chiotis K, Nordberg A. Alzheimer’s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline. Mol Psychiatry. 2021;26(10):5888–98.
Article
CAS
PubMed
PubMed Central
Google Scholar
Snitz BE, Brickman AM. Do subtle cognitive deficits precede amyloid accumulation?: Cart before the horse. Neurology. 2020;94(4):151–52.
Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer’s disease neuroimaging initiative (ADNI): clinical characterization. Neurology. 2010;74(3):201–9.
Article
PubMed
PubMed Central
Google Scholar
Saykin AJ, Wishart HA, Rabin LA, Santulli RB, Flashman LA, West JD, et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology. 2006;67(5):834–42.
Article
CAS
PubMed
Google Scholar
Thomas KR, Edmonds EC, Eppig JS, Wong CG, Weigand AJ, Bangen KJ, et al. MCI-to-normal reversion using neuropsychological criteria in the Alzheimer’s Disease Neuroimaging Initiative. Alzheimers Dement. 2019;15(10):1322–32.
Article
PubMed
PubMed Central
Google Scholar
Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014;42(1):275–89.
Article
PubMed
PubMed Central
Google Scholar
Jak AJ, Bondi MW, Delano-Wood L, Wierenga C, Corey-Bloom J, Salmon DP, et al. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry. 2009;17(5):368–75.
Article
PubMed
PubMed Central
Google Scholar
Risacher SL, Kim S, Nho K, Foroud T, Shen L, Petersen RC, et al. APOE effect on Alzheimer’s disease biomarkers in older adults with significant memory concern. Alzheimers Dement. 2015;11(12):1417–29.
Article
PubMed
PubMed Central
Google Scholar
Landau S, Ward TJ, Jagust WJ. Flortaucipir (AV-1451) processing methods. 2021. Available from: http://adni.loni.usc.edu/.
Schultz SA, Gordon BA, Mishra S, Su Y, Perrin RJ, Cairns NJ, et al. Widespread distribution of tauopathy in preclinical Alzheimer’s disease. Neurobiol Aging. 2018;72:177–85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data. Data Brief. 2017;15:648–57.
Article
PubMed
PubMed Central
Google Scholar
Weigand AJ, Bangen KJ, Thomas KR, Delano-Wood L, Gilbert PE, Brickman AM, et al. Is tau in the absence of amyloid on the Alzheimer’s continuum?: a study of discordant PET positivity. Brain Commun. 2020;2:fcz046.
Nation DA, Edmonds EC, Bangen KJ, Delano-Wood L, Scanlon BK, Han SD, et al. Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults. JAMA Neurol. 2015;72(5):546–53.
Article
PubMed
PubMed Central
Google Scholar
Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, Thomas RG, et al. The Preclinical Alzheimer Cognitive Composite: measuring amyloid-related decline. JAMA Neurol. 2014;71(8):961–70.
Article
PubMed
PubMed Central
Google Scholar
Royse SK, Minhas DS, Lopresti BJ, Murphy A, Ward T, Koeppe RA, et al. Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach. Alzheimers Res Ther. 2021;13(1):99.
Article
CAS
PubMed
PubMed Central
Google Scholar
Buckley RF, Hanseeuw B, Schultz AP, Vannini P, Aghjayan SL, Properzi MJ, et al. Region-specific association of subjective cognitive decline with tauopathy independent of global β-amyloid burden. JAMA Neurol. 2017;74(12):1455–63.
Article
PubMed
PubMed Central
Google Scholar
Shokouhi S, Conley AC, Baker SL, Albert K, Kang H, Gwirtsman HE, et al. The relationship between domain-specific subjective cognitive decline and Alzheimer’s pathology in normal elderly adults. Neurobiol Aging. 2019;81:22–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Swinford CG, Risacher SL, Charil A, Schwarz AJ, Saykin AJ. Memory concerns in the early Alzheimer’s disease prodrome: regional association with tau deposition. Alzheimers Dement. 2018;10:322–31.
Google Scholar
Buckley RF, Villemagne VL, Masters CL, Ellis KA, Rowe CC, Johnson K, et al. A conceptualization of the utility of subjective cognitive decline in clinical trials of preclinical Alzheimer’s disease. J Mol Neurosci. 2016;60(3):354–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Petersen RC, Wiste HJ, Weigand SD, Fields JA, Geda YE, Graff-Radford J, et al. NIA-AA Alzheimer’s Disease Framework: clinical characterization of stages. Ann Neurol. 2021;89(6):1145–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rabin LA, Smart CM, Crane PK, Amariglio RE, Berman LM, Boada M, et al. Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies. J Alzheimers Dis. 2015;48(s1):S63–86.
Article
PubMed
PubMed Central
Google Scholar
Tandetnik C, Farrell MT, Cary MS, Cines S, Emrani S, Karlawish J, et al. Ascertaining subjective cognitive decline: a comparison of approaches and evidence for using an age-anchored reference group. J Alzheimers Dis. 2015;48(s1):S43–55.
Article
PubMed
PubMed Central
Google Scholar
Hill NL, McDermott C, Mogle J, Munoz E, DePasquale N, Wion R, et al. Subjective cognitive impairment and quality of life: a systematic review. Int Psychogeriatr. 2017;29(12):1965–77.
Article
PubMed
Google Scholar
Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, et al. Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging. J Neurosci. 2018;38(3):530–43.
Article
CAS
PubMed
PubMed Central
Google Scholar